Discover how pharma can move from AI theory to practical implementation in launch strategies. Simone Rebora shares insights on overcoming key barriers, fostering cross-functional collaboration during digital transformation, and building a phased AI roadmap that delivers value at every stage. Plus, hear what he’s most looking forward to at the Pharmaceutical Launch Excellence Summit.
Ahead of the Pharma Launch Excellence Summit, Sherif Elhaw, Former Director, Emerging Markets, Launch Excellence Lead, Former Pfizer explores how pharma launches are shifting toward agile, localised strategies supported by cross-functional collaboration and digital innovation. Check it out below
Join us for a pre-event conversation with Laura Wallace, Former Global Head of Integrated Evidence at Boehringer Ingelheim, as she shares expert insights on designing cross-functional, cross-stakeholder evidence strategies for pharmaceutical launches. Discover how to align evidence needs across regulators, payers, HCPs, and patients, avoid late-stage gaps, and balance global consistency with local market adaptation.
[Speaker Interview] Sherif Elhaw, Director, Emerging Markets, Launch Excellence Lead at Pfizer shares insights on the evolving pharmaceutical launch landscape, emphasizing the importance of innovation, data-driven decision-making, and overcoming cognitive biases for successful product launches.
[Speaker Interview] Paula Albuquerque, Assets Strategic Planning, at UCB shares insights on evolving landscape of launch excellence, highlighting the importance of strategic agility, market access collaboration, and sustainable practices to ensure both corporate success and equitable patient outcomes.
[Speaker Video Interview] Simone Rebora, Global Marketing Director at Ipsen shares insights on building expertise, evolving in the industry, mastering successful launches and adapting global launch strategies.